Goldman Sachs’s MediWound MDWD Stock Holding History

Goldman Sachs’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$493K	Buy	33,552 +13,811	+70%	+$219K	﹤0.01%	5705
2026 Q1	$318K	Buy	+19,741	New	+$343K	﹤0.01%	5867
2025 Q4	–	Sell	-13,164	Closed	-$237K	–	6676
2025 Q3	$237K	Buy	+13,164	New	+$243K	﹤0.01%	5879
2025 Q2	–	Sell	-11,610	Closed	-$180K	–	6290
2025 Q1	$180K	Sell	11,610 -7,673	-40%	-$137K	﹤0.01%	5663
2024 Q4	$343K	Buy	19,283 +5,472	+40%	+$94.3K	﹤0.01%	5441
2024 Q3	$249K	Buy	+13,811	New	+$252K	﹤0.01%	5379
2021 Q4	–	Sell	-2,072	Closed	-$48K	–	6597
2021 Q3	$48K	Buy	+2,072	New	+$55.3K	﹤0.01%	6056
2016 Q4	–	Sell	-1,879	Closed	-$101K	–	7001
2016 Q3	$101K	Buy	+1,879	New	+$99.9K	﹤0.01%	6221
2015 Q1	–	Sell	-2,774	Closed	-$129K	–	7202
2014 Q4	$129K	Sell	2,774 -873	-24%	-$35.8K	﹤0.01%	6452
2014 Q3	$161K	Sell	3,647 -25	-0.7%	-$1.44K	﹤0.01%	6329
2014 Q2	$293K	Buy	+3,672	New	+$299K	﹤0.01%	5865

Other funds holding MDWD

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs's MDWD Position: Q2 2026 in Review

Goldman Sachs increased its MediWound (MDWD) stake by 70% in Q2 2026, buying an estimated $219K and bringing the position to 33,552 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #5705.

Goldman Sachs first reported a position in MDWD in Q2 2014 and has held it in 11 quarters since. 78 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

Goldman Sachs held 33,552 shares of MediWound worth $493K as of Q2 2026.
Goldman Sachs bought 13,811 MediWound shares in Q2 2026, an estimated $219K.
MediWound made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5705 holding.
Goldman Sachs first reported a position in MediWound in Q2 2014 and has held it in 11 quarters since.
78 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.